Pulmonary function testing (PFT) is a vital tool in diagnosing, managing, and monitoring respiratory diseases. It provides valuable insights into the functional capacity of the lungs, enabling physicians to make informed decisions about patient care. This article aims to provide a comprehensive guide on deciphering PFT results.
PFTs include a variety of non-invasive tests that measure how well the lungs function. These include spirometry, lung volumes, and diffusion capacity. Each test provides different information about the lungs, aiding in diagnosing various conditions such as asthma, bronchitis, and emphysema.
Spirometry measures the amount (volume) and speed (flow) of air that can be inhaled and exhaled. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and the FEV1/FVC ratio. Abnormal spirometry results can indicate obstructive or restrictive lung diseases.
Lung volumes provide information about the size of the lungs and their ability to expand. Total Lung Capacity (TLC), Functional Residual Capacity (FRC), and Residual Volume (RV) are key measures. Abnormalities in lung volumes can help identify restrictive diseases and conditions causing hyperinflation.
Diffusion capacity tests measure how effectively oxygen passes from the lungs to the bloodstream. The key parameter is the Diffusion Capacity of the Lungs for Carbon Monoxide (DLCO). Reduced DLCO can indicate conditions such as pulmonary fibrosis or pulmonary hypertension.
Understanding and interpreting PFTs is crucial in respiratory medicine. It aids in diagnosing various lung diseases, assessing disease severity, and monitoring response to treatment. With the knowledge of key parameters from spirometry, lung volumes, and diffusion capacity, medical professionals can effectively utilize PFTs to enhance patient care.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation